In CF, disease-causing mutations in CFTR lead to dysregulated ASL fluid volume and composition in the lung which is associated with increased mucus viscosity, increased susceptibility to pathogens, and modulated lung immunity6–9. The gene discussed is CFTR; the disease is cystic fibrosis.